Who owns Nektar Therapeutics?

Key details on Nektar Therapeutics (Ticker: NKTR)

Who owns Nektar Therapeutics?

Is NKTR a good stock to own? Find out who bought Nektar Therapeutics, who sold Nektar Therapeutics (NKTR) stock, and who holds a large position in Nektar Therapeutics.

Fund Name Number of Shares Share Valuation As Of
OppenheimerFunds 23.00M $261.05M Dec. 31, 2013
PRIMECAP Management Company 12.50M $141.86M Dec. 31, 2013
HealthCor Management 9.20M $66.88M June 30, 2011
Vanguard 7.53M $85.44M Dec. 31, 2013
Federated Investors 5.25M $59.59M Dec. 31, 2013
Ulys 5.17M $28.93M Dec. 31, 2011
BlackRock Fund Advisors 4.33M $49.17M Dec. 31, 2013
First Trust Advisors 4.32M $48.98M Dec. 31, 2013
STATE STREET CORPORATION 4.31M $48.87M Dec. 31, 2013
HealthCor Management 4.00M $46.20M June 30, 2013
GRANAHAN INVESTMENT MANAGEMENT INC/MA 3.69M $44.77M March 31, 2014
BlackRock Institutional Trust Company, N.A. 3.19M $36.18M Dec. 31, 2013
Deerfield Management Company 2.94M $33.95M June 30, 2013
Invus Public Equities Advisors 2.75M $19.99M June 30, 2011
BVF 2.73M $20.26M Dec. 31, 2012
Barclays 2.71M $21.48M March 31, 2012
Artal Group S.A. 2.30M $24.04M Sept. 30, 2013
Franklin Resources 2.28M $25.92M Dec. 31, 2013
Tang Capital Management 2.20M $23.50M Sept. 30, 2012
NEA Management Company 1.83M $20.72M Dec. 31, 2013
JPMORGAN CHASE & CO 1.80M $20.39M Dec. 31, 2013
Millennium Management 1.73M $18.99M March 31, 2013
Legg Mason Capital Management 1.67M $13.23M March 31, 2012
NORTHERN TRUST 1.67M $18.94M Dec. 31, 2013
SYSTEMATIC FINANCIAL MANAGEMENT 1.64M $18.61M Dec. 31, 2013
Redmile 1.52M $12.07M March 31, 2012
T. Rowe Price Associates 1.51M $17.49M June 30, 2013

Who sold Nektar Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
ALLIANCEBERNSTEIN March 31, 2011 1.52M $14.38M
Columbia Wanger Asset Management Dec. 31, 2010 3.49M $44.80M
Tudor Investment Corporation Dec. 31, 2005 1.72M $28.26M
Maverick Capital Dec. 31, 2004 2.47M $50.04M